December 14, 2020
VANCOUVER, BC / ACCESSWIRE / December 14, 2020 / Eastwest Bioscience Inc. (TSXV:EAST)(“Eastwest” or the “Corporation“) provides this bi-weekly default status report in accordance with National Policy […]
December 1, 2020
VANCOUVER, BC / ACCESSWIRE / December 1, 2020 / Eastwest Bioscience Inc. (“Eastwest” or the “Corporation“) provides this default announcement indicating Eastwest’s anticipated failure to file its […]
November 17, 2020
VANCOUVER, BC / ACCESSWIRE / November 17, 2020 / EastWest Bioscience Inc. (the “Company” or “EastWest“) (TSXV:EAST) announces the issuance of 613,467 common shares at a price of CDN […]
October 22, 2020
Penticton, BC / October 21, 2020 / EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) EastWest is pleased to announce the appointment of Carlo Bevilacqua as […]
July 23, 2020
PENTICTON, BC / ACCESSWIRE / July 23, 2020 / EastWest Bioscience (the “Company” or “EastWest“) (TSXV:EAST) reports that, on July 8, 2020, the US Securities and Exchange […]
June 30, 2020
Key highlights of third quarter of 2020 fiscal year Total expenses for the three months ended were $520,274 as compared to $1,158,648 for the same period […]
June 25, 2020
PENTICTON, BC / ACCESSWIRE / June 25, 2020 / EastWest Bioscience (the “Company” or “EastWest“) (TSXV:EAST) is pleased to announce that further to the Company’s press release […]
June 19, 2020
VANCOUVER, BC / ACCESSWIRE / June 18, 2020 / EastWest Bioscience (the “Company” or “EastWest“) (TSXV:EAST) announces that it intends to conduct a private placement financing of […]
June 15, 2020
VANCOUVER, BC / ACCESSWIRE / June 15, 2020 / EastWest Bioscience (the “Company” or “EastWest“) (TSXV:EAST) announces the issuance of approximately 6,007,270 common shares at a price […]